Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Buy
1,146
+371
+48% +$105K 0.01% 308
2026
Q1
$207K Sell
775
-66
-8% -$18.3K 0.01% 333
2025
Q4
$231K Buy
841
+109
+15% +$30.6K 0.01% 306
2025
Q3
$211K Sell
732
-164
-18% -$48.5K 0.01% 292
2025
Q2
$296K Buy
896
+95
+12% +$30.6K 0.01% 255
2025
Q1
$264K Buy
801
+17
+2% +$5.12K 0.01% 251
2024
Q4
$216K Sell
784
-7
-0.9% -$2.23K 0.01% 274
2024
Q3
$274K Sell
791
-4
-0.5% -$1.38K 0.01% 244
2024
Q2
$263K Sell
795
-417
-34% -$144K 0.01% 247
2024
Q1
$440K Sell
1,212
-2
-0.2% -$658 0.02% 209
2023
Q4
$364K Sell
1,214
-267
-18% -$78K 0.02% 222
2023
Q3
$424K Buy
1,481
+262
+21% +$74.7K 0.02% 195
2023
Q2
$342K Hold
1,219
0.02% 208
2023
Q1
$311K Sell
1,219
-18
-1% -$5.25K 0.02% 215
2022
Q4
$410K Buy
1,237
+336
+37% +$106K 0.02% 192
2022
Q3
$250K Buy
901
+79
+10% +$22.2K 0.01% 227
2022
Q2
$216K Sell
822
-43
-5% -$11.1K 0.01% 255
2022
Q1
$208K Sell
865
-9
-1% -$2.11K 0.01% 263
2021
Q4
$202K Buy
+874
New +$186K 0.01% 275
2019
Q2
Sell
-1,922
Closed -$305K 231
2019
Q1
$305K Sell
1,922
-206
-10% -$37.6K 0.02% 180
2018
Q4
$408K Buy
2,128
+1,128
+113% +$235K 0.03% 154
2018
Q3
$208K Buy
+1,000
New +$185K 0.02% 223

Other funds holding CI

Aspiriant LLC's CI Position: Q2 2026 in Review

Aspiriant LLC increased its Cigna (CI) stake by 48% in Q2 2026, buying an estimated $105K and bringing the position to 1,146 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #308.

Aspiriant LLC first reported a position in CI in Q3 2018 and has held it in 22 quarters since. The position peaked at $440K in Q1 2024. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Aspiriant LLC held 1,146 shares of Cigna worth $316K as of Q2 2026.
  • Aspiriant LLC bought 371 Cigna shares in Q2 2026, an estimated $105K.
  • Cigna made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #308 holding.
  • Aspiriant LLC first reported a position in Cigna in Q3 2018 and has held it in 22 quarters since.
  • Aspiriant LLC's Cigna position peaked at $440K in Q1 2024.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.